Afs Financial Group, LLC Merck & Co., Inc. Transaction History

Afs Financial Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 23, 2024	SELL	$100.18 - $109.02 $915,945 - $996,769	-9,143 Reduced 57.08%	6,875 $750 Million
Q3 2023 Oct 13, 2023	SELL	$102.95 - $114.33 $26,767 - $29,725	-260 Reduced 1.6%	16,018 $1.65 Billion
Q2 2023 Jul 17, 2023	SELL	$108.61 - $118.38 $118,384 - $129,034	-1,090 Reduced 6.28%	16,278 $1.88 Billion
Q1 2023 Apr 20, 2023	BUY	$102.94 - $114.86 $12,146 - $13,553	118 Added 0.68%	17,368 $1.85 Billion
Q4 2022 Jan 25, 2023	BUY	$87.44 - $112.11 $1.51 Million - $1.93 Million	17,250 New	17,250 $1.91 Billion

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Afs Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Afs Financial Group, LLC with notifications on news.